An interventional study of Sauna and Reduced Physical Activity in Physical Inactivity, Vascular Dysfunction and Skeletal Muscle Atrophy, sponsored by Brigham Young University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.
Sponsored by Brigham Young University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 452 studies in Sedentary Behavior with a site in United States — 61 open to participants now, 89 under way, none of them phase 3. Sedentary Behavior · United States.
Among the 452 studies in Sedentary Behavior with a site in United States, this one is the 196th largest by planned enrollment of the 421 interventional ones that give a count, is one of 21 that started in 2026, is one of 386 with no phase, reaches primary completion later than 39 of the 88 other live ones, and was the 447th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →61 of the 452 studies in Sedentary Behavior with a site in United States are open now. Recruiting first, the newest first:
St. Louis University · Sites in United States
Ages 18–69
University of Pittsburgh · Sites in United States
Ages 14–26
University of Wisconsin, River Falls · Sites in United States
Ages 18–60 · Healthy volunteers
The University of Tennessee, Knoxville · Sites in United States
Ages 65+
San Diego State University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
452 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 19 · Phase 2 15 · Phase 3 3 · Phase 4 2
First in 2000; this study’s year is marked. 21 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is close to the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 60 across the 421 interventional studies, 122 across the 30 observational. Of the 335 that completed or were terminated, 105 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 452 have an industry lead sponsor. The 10 most frequent:
Brigham Young University is the lead sponsor of 17 studies on the registry; 3 are open to participants now.
Brigham Young University has 1 study filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
40 of the studies in Sedentary Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520786University of GeorgiaChanges in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women | 2026-11 |
| NCT06923397Dana-Farber Cancer InstituteInterrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | 2026-11-28 |
| NCT06116435University of Colorado, DenverA Pilot Factorial Trial of an Integrated Lifestyle Intervention | 2026-12 |
| NCT06754280University of Illinois at ChicagoAn Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease | 2026-12 |
| NCT07270016University of PittsburghPilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes | 2026-12 |
Add all 40 to your calendar (.ics) → With an account.
Among the 452 studies in Sedentary Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this randomized controlled trial is to determine whether daily Finnish dry sauna therapy attenuates the adverse cardiovascular, muscular, and metabolic effects of seven days of experimentally reduced physical activity in healthy adults.
Participants will be randomized to one of three groups: (1) maintained habitual physical activity with daily sauna therapy, (2) reduced physical activity with daily room-temperature sauna visits (control), or (3) reduced physical activity with daily sauna therapy. Reduced physical activity will be achieved by decreasing daily step count to approximately 1,000 steps per day with the assistance of a power wheelchair.
Outcome measures include vascular endothelial function, exercise tolerance, muscle protein synthesis, body composition, blood pressure, glucose regulation, and physiological responses to heat exposure. The study will determine whether passive heat therapy can serve as a practical intervention to preserve cardiometabolic health during short periods of reduced mobility.
Reduced physical activity resulting from illness, injury, hospitalization, or other temporary limitations rapidly impairs cardiovascular, skeletal muscle, and metabolic health. Even short-term reductions in daily physical activity are associated with decreased endothelial function, reduced aerobic capacity, loss of muscle mass, and impaired insulin sensitivity.
Previous work from our laboratory has demonstrated that localized heat therapy producing exercise-like increases in muscle temperature attenuates several detrimental adaptations associated with limb immobilization. The present study investigates whether whole-body heat therapy delivered through Finnish dry sauna bathing can similarly reduce the adverse effects of whole-body reductions in physical activity.
Healthy adults will be randomly assigned to one of three intervention groups:
The intervention will last seven days. Cardiovascular function, exercise tolerance, muscle protein synthesis, body composition, glucose regulation, blood pressure, and additional physiological variables will be assessed before and after the intervention. The findings will determine whether passive heat therapy is an effective strategy for preserving cardiometabolic health during temporary reductions in physical activity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will maintain their habitual level of physical activity for seven consecutive days while undergoing one supervised Finnish dry sauna session each day. Sauna treatments will consist of standard Finnish dry sauna exposure according to the study protocol. Participants will undergo comprehensive cardiovascular, muscular, metabolic, and physiological assessments before and after the intervention.
Device: Sauna
Participants will reduce daily physical activity to approximately 1,000 steps per day for seven consecutive days with assistance from a power wheelchair. Participants will attend daily room-temperature sauna sessions that replicate the timing and environment of the sauna intervention without therapeutic heat exposure. Comprehensive outcome assessments will be completed before and after the intervention.
Behavioral: Reduced Physical Activity
Participants will reduce daily physical activity to approximately 1,000 steps per day for seven consecutive days with assistance from a power wheelchair while also completing one supervised Finnish dry sauna session each day. Outcome measures will be assessed before and after the intervention to determine whether heat therapy attenuates the adverse physiological effects of reduced physical activity.
Device: Sauna · Behavioral: Reduced Physical Activity
Participants will complete one supervised dry sauna session each day for seven consecutive days. Sauna exposure will be delivered according to the study protocol using a standard Finnish dry sauna.
Participants will reduce daily step count to approximately 1,000 steps per day for seven consecutive days. A power wheelchair will be used to assist participants in minimizing ambulation while maintaining normal daily activities.
Femoral artery endothelial function
Common femoral artery blood flow will be measured using Doppler ultrasound at rest and during passive movement of the lower leg through approximately 90 degrees of motion. The hyperemic response may be expressed as peak blood flow, change from resting blood flow, and/or blood-flow area under the curve. The change from baseline to post-intervention will be compared among groups.
Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)
Change in Maximum Knee-Extension Cycling Power
Maximum exercise power will be determined during a graded knee-extension cycling test in which resistance is progressively increased until the participant can no longer maintain the required cadence. Maximum power will be reported in watts.
Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)
Change in Whole-Body Lean Mass
Whole-body lean mass will be measured using dual-energy X-ray absorptiometry. Lean mass will be reported in kilograms, and the change from baseline to post-intervention will be compared among groups.
Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)
Integrated Skeletal Muscle Protein Synthesis Rate
The integrated fractional synthesis rate of skeletal muscle protein will be determined using deuterium oxide labeling and vastus lateralis muscle biopsies. Deuterium incorporation into newly synthesized muscle protein will be quantified by mass spectrometry and expressed as the fractional synthesis rate over the study period, such as percentage per day. Rates will be compared among the three intervention groups.
Time frame: Baseline (Day -4) and Day 8
Change in Leg Lean Mass
Regional leg lean mass will be measured using dual-energy X-ray absorptiometry and reported in kilograms. The change from baseline to post-intervention will be compared among groups.
Time frame: This outcome will be assessed four days prior to the start of the intervention (Day -4) and again 1 day following the final sauna visit (Day 8)
Change in Mean Interstitial Glucose Concentration
Interstitial glucose concentrations will be monitored using a continuous glucose monitor. Mean glucose concentration will be calculated for the habitual-activity or baseline monitoring period and for the 7-day intervention period and reported in milligrams per deciliter.
Time frame: Days -4, -3, -2, -1, 0, 1, 2, 3, 4, 5, 6, 7, 8
Mean Daily Step Count During the Intervention
Daily physical activity will be measured using an accelerometer worn on the wrist, ankle, or waist. Mean steps per day during the 7-day intervention will be used to assess adherence to the habitual-activity or reduced-activity assignment.
Time frame: Days -4, -3, -2, -1, 0, 1, 2, 3, 4, 5, 6, 7, 8
Change in Core Temperature During Sauna Exposure
Core temperature will be measured using an esophageal temperature probe during the first and final sauna treatments. The change from pre-sauna temperature to peak temperature during sauna will be reported in degrees Celsius.
Time frame: Day 1 and Day 8
Plan to share: No — Individual participant data will not be shared because participant consent did not include public data sharing, and protection of participant confidentiality is a priority.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 12 months is below that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham Young University